These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 27544303)
1. Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors. de Morais H; de Souza CP; da Silva LM; Ferreira DM; Baggio CH; Vanvossen AC; Cristina de Carvalho M; da Silva-Santos JE; Bertoglio LJ; Cunha JM; Zanoveli JM Eur Neuropsychopharmacol; 2016 Oct; 26(10):1590-600. PubMed ID: 27544303 [TBL] [Abstract][Full Text] [Related]
2. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats. Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460 [TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors. Sartim AG; Guimarães FS; Joca SR Behav Brain Res; 2016 Apr; 303():218-27. PubMed ID: 26801828 [TBL] [Abstract][Full Text] [Related]
4. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats. Schreiber AK; Neufeld M; Jesus CH; Cunha JM Neuropharmacology; 2012 Dec; 63(8):1286-97. PubMed ID: 22959964 [TBL] [Abstract][Full Text] [Related]
5. The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes. Pereira MM; de Morais H; Dos Santos Silva E; Corso CR; Adami ER; Carlos RM; Acco A; Zanoveli JM Metab Brain Dis; 2018 Oct; 33(5):1573-1584. PubMed ID: 29934859 [TBL] [Abstract][Full Text] [Related]
6. Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats. de Morais H; de Souza CP; da Silva LM; Ferreira DM; Werner MF; Andreatini R; da Cunha JM; Zanoveli JM Behav Brain Res; 2014 Jan; 258():52-64. PubMed ID: 24140504 [TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors. Desroches J; Charron S; Bouchard JF; Beaulieu P Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808 [TBL] [Abstract][Full Text] [Related]
8. CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy. Medeiros P; de Freitas RL; Silva MO; Coimbra NC; Melo-Thomas L Neuroscience; 2016 Nov; 337():17-26. PubMed ID: 27595886 [TBL] [Abstract][Full Text] [Related]
9. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors. Romero TR; Pacheco Dda F; Duarte ID Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446 [TBL] [Abstract][Full Text] [Related]
10. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131 [TBL] [Abstract][Full Text] [Related]
11. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes. Al Kury LT; Voitychuk OI; Ali RM; Galadari S; Yang KH; Howarth FC; Shuba YM; Oz M Cell Calcium; 2014 Feb; 55(2):104-18. PubMed ID: 24472666 [TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat. Rettori E; De Laurentiis A; Zorrilla Zubilete M; Rettori V; Elverdin JC Neuroimmunomodulation; 2012; 19(5):293-303. PubMed ID: 22777139 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of salivary secretion by activation of cannabinoid receptors. Prestifilippo JP; Fernández-Solari J; de la Cal C; Iribarne M; Suburo AM; Rettori V; McCann SM; Elverdin JC Exp Biol Med (Maywood); 2006 Sep; 231(8):1421-9. PubMed ID: 16946411 [TBL] [Abstract][Full Text] [Related]
14. [Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts]. Liao YS; Wu J; Wang P; Zhang H Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):256-9. PubMed ID: 21575494 [TBL] [Abstract][Full Text] [Related]
15. N‑linoleyltyrosine protects PC12 cells against oxidative damage via autophagy: Possible involvement of CB1 receptor regulation. Liu X; Wu Y; Zhou D; Xie Y; Zhou Y; Lu Y; Yang R; Liu S Int J Mol Med; 2020 Nov; 46(5):1827-1837. PubMed ID: 33000188 [TBL] [Abstract][Full Text] [Related]
16. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray. Lisboa SF; Guimarães FS Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688 [TBL] [Abstract][Full Text] [Related]
17. Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. Citraro R; Russo E; Scicchitano F; van Rijn CM; Cosco D; Avagliano C; Russo R; D'Agostino G; Petrosino S; Guida F; Gatta L; van Luijtelaar G; Maione S; Di Marzo V; Calignano A; De Sarro G Neuropharmacology; 2013 Jun; 69():115-26. PubMed ID: 23206503 [TBL] [Abstract][Full Text] [Related]
18. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion. da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884 [TBL] [Abstract][Full Text] [Related]
19. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors. Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671 [TBL] [Abstract][Full Text] [Related]